JDD Highlights

The Latest on Oncodermatology, Psoriasis, Atopic Dermatitis & More

Dermatology News

JDD Highlights

The May issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin Cancer, with special features on Public Health, Atopic Dermatitis, Psoriasis, and more.

Read the JDD Now

Oncodermatology, Psoriasis, Atopic Dermatitis & More

The May issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin Cancer, with special features on Public Health, Atopic Dermatitis, Psoriasis, and more.

Article Highlights

Editor's Picks

Aesthetics

You May Also Like

Featured ArticlesThe Latest
November 21, 2024

Isobutylamido Thiazolyl Resorcinol (Thiamidol) for Combatting Hyperpigmentation: A Systematic Review of Clinical Studies

JDD Article Highlights A powerful new contender in the fight against hyperpigmentation is making waves—Isobutylamido Thiazolyl Resorcinol (ITR). Recent studies reveal its potential as a potent inhibitor of human tyrosinase,…
Atopic DermatitisDermatology RoundupGlobal HealthJDD HighlightsJDD in the MediaSkin CancerThe Latest
November 20, 2024

Dermatology Roundup: Medicare Fee Schedule to Cut Physician Pay; Telemedicine Tool Found Accurate in Melanoma Diagnosis

By Allison Sit The American Academy of Dermatology (AAD) is joining with other specialties in speaking out about cuts to the Medicare Physician Fee Schedule for 2025. The physician services…
Featured ArticlesThe Latest
November 20, 2024

Safety and Effectiveness of Synchronized Monopolar Radiofrequency and HIFES in Patients Injected With Botulinum Toxin

JDD Article Highlights Botulinum toxin (BT) is a go-to for wrinkle reduction, but what if there's a way to make it even more effective? JDD  published a study that explores…

Leave a Reply